Peregrine Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $561k | 86k | 6.50 |
| 2023-09-30 | $1.4M | 147k | 9.44 |
| 2023-06-30 | $2.1M | 148k | 13.97 |
| 2023-03-31 | $3.4M | 182k | 18.76 |
| 2022-12-31 | $2.4M | 172k | 13.77 |
| 2022-09-30 | $3.2M | 168k | 19.12 |
| 2022-06-30 | $2.5M | 162k | 15.26 |
| 2022-03-31 | $2.4M | 117k | 20.37 |
| 2021-12-31 | $4.2M | 143k | 29.18 |
| 2021-09-30 | $1.4M | 65k | 21.57 |
| 2021-06-30 | $1.6M | 63k | 25.64 |
| 2021-03-31 | $1.2M | 67k | 18.23 |
| 2020-12-31 | $811k | 70k | 11.55 |
| 2020-09-30 | $502k | 66k | 7.62 |
| 2020-06-30 | $494k | 75k | 6.57 |
| 2020-03-31 | $364k | 71k | 5.11 |
| 2019-12-31 | $545k | 71k | 7.68 |
| 2019-09-30 | $375k | 71k | 5.31 |
| 2019-06-30 | $395k | 71k | 5.60 |
| 2019-03-31 | $275k | 65k | 4.24 |
| 2018-12-31 | $274k | 67k | 4.10 |
| 2018-09-30 | $300k | 44k | 6.86 |
| 2018-06-30 | $174k | 44k | 3.92 |